|
Description:
|
|
In this episode of SurgOnc Today®, Dr. Rebecca Snyder, from the UT MD Anderson Cancer Center, and Dr. Akhil Chawla, from Northwestern University, both members of the HPB disease site working group, are joined by Dr. Cristina Ferrone, from Cedars Sinai Medical Center, and Dr. Steven Gallinger, from the University of Toronto. We will discuss the details, similarities, and differences of their respective clinical trials for neoadjuvant therapy for pancreatic adenocarcinoma, ALLIANCE A021806, and NeoPancONE. References/Resources: ALLIANCE A021806 NeoPancONE |